continue

Xinhua Silk Road: Chinese baijiu maker Fenjiu to continue as bridge of communication, cooperation among Global South

BEIJING, April 17, 2026 /PRNewswire/ -- Chinese baijiu maker Fenjiu Group has pledged to continue to serve as a bridge for…

2 weeks ago

Mobile Money accounted for $2 trillion in transactions in 2025, doubling since 2021 as active accounts continue to grow

Monthly active mobile money accounts saw their highest growth since 2021.LONDON, March 24, 2026 /PRNewswire/ -- More than $2 trillion…

1 month ago

argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline

Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as the first targeted treatment for patients living with…

2 months ago

ValueLabs to Continue Growth Journey as an Independent, Founder-Led Company

HYDERABAD, India, Jan. 15, 2026 /PRNewswire/ -- ValueLabs, a global digital engineering and enterprise AI company, today announced that it…

3 months ago

React19 Launches This Is Our Shot Campaign as U.S. Vaccine Injury Victims Continue to Go Unheard and Uncompensated

SALT LAKE CITY, Nov. 06, 2025 (GLOBE NEWSWIRE) -- As the federal government’s Countermeasures Injury Compensation Program (CICP) has approved…

6 months ago

Hyundai Motor Group and Rhode Island School of Design Continue Partnership Exploring Advanced Biodesign and the Future of Mobility

In its sixth year, the annual research collaboration continues to examine the convergence of biodesign and biomimicry, advanced art and…

6 months ago

AvePoint Announces Dual Listing on the Singapore Exchange to Continue Global Expansion

JERSEY CITY, N.J., Sept. 18, 2025 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT, SGX: AVP), the global leader in data security,…

7 months ago

Asian Nations Dominate Passport Power Ranking as US and UK Continue to Decline

LONDON, July 22, 2025 /PRNewswire/ -- Singapore holds the crown as the world's most powerful passport, with visa-free access to…

9 months ago

Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML

SAN DIEGO and TORONTO, July 15, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC:…

10 months ago

Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a…

10 months ago